AcquisitionOther
Global Blood Therapeutics, Inc. acquired Global Blood Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Global Blood Therapeutics, Inc. -> Global Blood Therapeutics · $5.4 Billion
The acquisition complements and further enhances Pfizer’s more than 30-year heritage in rare hematology and reinforces the company’s commitment to SCD by bringing expertise and a leading portfolio and pipeline with the potential to address the full spectrum of
Open source record (SEC) ↗